Wang H, Pan L, Liu Z. Neutrophils as a protagonist and target in chronic rhinosinusitis. Clin Exp Otorhinolaryngol. 2019;12:337–47. https://doi.org/10.21053/ceo.2019.00654.
Article CAS PubMed PubMed Central Google Scholar
Shin JH, Roh D, Lee DH, Kim SW, Kim SW, Cho JH, et al. Allergic rhinitis and rhinosinusitis synergistically compromise the mental health and health-related quality of life of Korean adults: a nationwide population-based survey. PLoS One. 2018;13:e0191115. https://doi.org/10.1371/journal.pone.0191115.
Article CAS PubMed PubMed Central Google Scholar
Lee K, Tai J, Lee SH, Kim TH. Advances in the knowledge of the underlying airway remodeling mechanisms in chronic rhinosinusitis based on the endotypes: a review. Int J Mol Sci. 2021;22:910–26. https://doi.org/10.3390/ijms22020910.
Article CAS PubMed PubMed Central Google Scholar
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464. https://doi.org/10.4193/RHIN20.600.
Irfan M, Shamim AK. Routine histological examination for nasal polyp specimens: is it necessary? Med J Malaysia. 2009;64:59–60.
Gevaert P, De Craemer J, Bachert C, Blauwblomme M, Chaker A, Cingi C, et al. European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis. Allergy. 2023;78:912–22. https://doi.org/10.1111/all.15650.
Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11:213–739. https://doi.org/10.1002/alr.22741.
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022;77:812–26. https://doi.org/10.1111/all.15074.
Hao D, Wu Y, Li P, Li C, Jiang T, Zhang Q, et al. An integrated analysis of inflammatory endotypes and clinical characteristics in chronic rhinosinusitis with nasal polyps. J Inflamm Res. 2022;15:5557–65. https://doi.org/10.2147/JIR.S377301.
Article CAS PubMed PubMed Central Google Scholar
Ruan J-W, Zhao J-F, Li X-L, Liao B, Pan L, Zhu K-Z, et al. Characterizing the neutrophilic inflammation in chronic rhinosinusitis with nasal polyps. Front Cell Dev Biol. 2021;9:1–16. https://doi.org/10.3389/fcell.2021.793073.
Stevens WW, Peters AT, Tan BK, Klingler AI, Poposki JA, Hulse KE, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7:2812–20. https://doi.org/10.1016/j.jaip.2019.05.009.
Article PubMed PubMed Central Google Scholar
Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, et al. Pathobiology of dynorphins in trauma and disease. Front Biosci. 2005;10:216–35.
Article CAS PubMed PubMed Central Google Scholar
Goldstein A, Fischli W, Lowney LI, Hunkapiller M, Hood L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc Natl Acad Sci U S A. 1981;78:7219–23. https://doi.org/10.1073/pnas.78.11.7219.
Article CAS PubMed PubMed Central Google Scholar
Ballouze R, Salhimi SM, Mohtar N, Fazalul Rahiman SS. Dynorphin 1–17 biotransformation peptides: properties, challenges and solutions for future therapeutics development. Future Med Chem. 2023;15:791–808. https://doi.org/10.4155/fmc-2023-0016.
Article CAS PubMed Google Scholar
Stein C, Machelska H. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol Rev. 2011;63:860–81. https://doi.org/10.1124/pr.110.003145.
Article CAS PubMed Google Scholar
Schreiter A, Gore C, Labuz D, Fournie-Zaluski MC, Roques BP, Stein C, et al. Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue. FASEB J. 2012;26:5161–71. https://doi.org/10.1096/fj.12-208678.
Article CAS PubMed Google Scholar
Morgan M, Heffernan A, Benhabib F, Wagner S, Hewavitharana AK, Shaw PN, et al. The efficacy of dynorphin fragments at the κ, μ and δ opioid receptor in transfected HEK cells and in an animal model of unilateral peripheral inflammation. Peptides. 2017;89:9–16. https://doi.org/10.1016/j.peptides.2016.12.019.
Article CAS PubMed Google Scholar
Morgan M, Herath HMDR, Cabot PJ, Shaw PN, Hewavitharana AK. Dynorphin A 1–17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2012;404:3111–21. https://doi.org/10.1007/s00216-012-6406-8.
Article CAS PubMed Google Scholar
Quillan JM, Sadée W. Dynorphin peptides: antagonists of melanocortin receptors. Pharm Res. 1997;14:713–9. https://doi.org/10.1023/A:1012185919153.
Article CAS PubMed Google Scholar
Lai J, Luo MC, Chen Q, Ma S, Gardell LR, Ossipov MH, et al. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci. 2006;9:1534–40. https://doi.org/10.1038/nn1804.
Article CAS PubMed Google Scholar
Fazalul Rahiman SS, Morgan M, Gray P, Shaw PN, Cabot PJ. Dynorphin 1–17 and its N-terminal biotransformation fragments modulate lipopolysaccharide-stimulated nuclear factor-kappa B nuclear translocation, interleukin-1beta and tumor necrosis factor-alpha in differentiated THP-1 cells. PLoS One. 2016;11:e0153005. https://doi.org/10.1371/journal.pone.0153005.
Article CAS PubMed PubMed Central Google Scholar
Cabot PJ, Carter L, Schäfer M, Stein C. Methionine-enkephalin and dynorphin A release from immune cells and control of inflammatory pain. Pain. 2001;93:207–12. https://doi.org/10.1016/S0304-3959(01)00322-0.
Article CAS PubMed Google Scholar
Lee SJ, Logsdon AF, Yagi M, Baskin BM, Peskind ER, Raskind MM, et al. The dynorphin/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma. J Neuroinflammation. 2022;19:288–303. https://doi.org/10.1186/s12974-022-02643-3.
Article CAS PubMed PubMed Central Google Scholar
Kong L-Y, McMillian MK, Hudson PM, Jin L, Hong J-S. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther. 1997;280:61–6.
Kong L-Y, Jeohn GH, Hudson PM, Du L, Liu B, Hong J-S. Reduction of lipopolysaccharide-induced neurotoxicity in mouse mixed cortical neuron/glia cultures by ultralow concentrations of dynorphins. J Biomed Sci. 2000;7:241–7. https://doi.org/10.1007/BF02255472.
Article CAS PubMed Google Scholar
Wei ET, Thomas HA, Gjerde EA, Reed RK, Burov SV, Korolkov VI, et al. Dynorphin A (6–12) analogs suppress thermal edema. Peptides. 1998;19:767–75. https://doi.org/10.1016/S0196-9781(97)00473-7.
Article CAS PubMed Google Scholar
Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci. 2018;41:453–73. https://doi.org/10.1146/annurev-neuro-080317-061522.
Article CAS PubMed PubMed Central Google Scholar
Klimas R, Mikus G. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Br J Anaesth. 2014;113:935–44. https://doi.org/10.1093/bja/aeu186.
Article CAS PubMed Google Scholar
Magnusson K, Hallberg M, Bergquist J, Nyberg F. Enzymatic conversion of dynorphin A in the rat brain is affected by administration of nandrolone decanoate. Peptides. 2007;28:851–8. https://doi.org/10.1016/j.peptides.2006.12.011.
Article CAS PubMed Google Scholar
Herath HMDR, Cabot PJ, Shaw PN, Hewavitharana AK. Study of beta-endorphin metabolism in inflamed tissue, serum and trypsin solution by liquid chromatography-tandem mass spectrometric analysis. Anal Bioanal Chem. 2012;402:2089–100. https://doi.org/10.1007/s00216-011-5686-8.
Article CAS PubMed Google Scholar
Reeh PW, Steen KH. Chapter 8. Tissue acidosis in nociception and pain. Prog Brain Res. 1996;113:143–51. https://doi.org/10.1016/S0079-6123(08)61085-7.
Article CAS PubMed Google Scholar
International Council for Harmonization of Technical requirements for Pharmaceuticals for human. ICH Harmonised Guideline: validation of analytical procedures Q2 (R2). Geneva: ICH; 2022.
Beaudry F, Ferland CE, Vachon P. Identification, characterization and quantification of specific neuropeptides in rat spinal cord by liquid chromatography electrospray quadrupole ion trap mass spectrometry. Biomed Chromatogr. 2009;23:940–50. https://doi.org/10.1002/bmc.1206.
Article CAS PubMed Google Scholar
Klintenberg R, Andrén PE. Altered extra
Comments (0)